de la Calle et al. [76] aimed to predict the recurrence and progression of PCa based on biomarker analysis from 648 samples (424 tumors, 224 normal tissue) using tissue micro assays anti Ki-67, anti ERG (erythroblast transformation-specific related gene) antibodies through an AI algorithm, having 100% identification of ERG positive tumors. This evidence concerns the gene ERG and posterior cortical atrophy.